{"transactions":[{"id":691948,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Series B Preferred Stock","published_at":"2026-08-10T22:22:07.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":124779,"ownership":{"direct":false,"nature":"By RongShan, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is the manager of RongShan, LLC. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of\nSection 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":124779},"source":{"system":"sec-edgar","filing":"0001772259-26-000005","document":"form4-08102026_100800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177225926000005/form4-08102026_100800.xml","form_type":"4"}},{"id":691947,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Series B Preferred Stock","published_at":"2026-08-10T22:22:07.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":113435,"ownership":{"direct":false,"nature":"By The Li and Cui Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of The Li and Cui Family Trust (the \"Trust\") and have voting and dispositive power over the securities held by the Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":113435},"source":{"system":"sec-edgar","filing":"0001772259-26-000005","document":"form4-08102026_100800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177225926000005/form4-08102026_100800.xml","form_type":"4"}},{"id":691946,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Series Angel Preferred Stock","published_at":"2026-08-10T22:22:07.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":1600682,"ownership":{"direct":false,"nature":"By The Li and Cui Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of The Li and Cui Family Trust (the \"Trust\") and have voting and dispositive power over the securities held by the Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1600682},"source":{"system":"sec-edgar","filing":"0001772259-26-000005","document":"form4-08102026_100800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177225926000005/form4-08102026_100800.xml","form_type":"4"}},{"id":691945,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-10T22:22:07.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":676205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest on August 6, 2027, and the balance of the shares shall vest in equal monthly installments over the following 36 months."}],"balance_after":676205,"derivative":{"exercise_price":16,"expiration_date":"2036-08-05","underlying":"Common Stock","underlying_shares":676205},"source":{"system":"sec-edgar","filing":"0001772259-26-000005","document":"form4-08102026_100800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177225926000005/form4-08102026_100800.xml","form_type":"4"}},{"id":691944,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-10T22:22:07.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":124779,"ownership":{"direct":false,"nature":"By RongShan, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is the manager of RongShan, LLC. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of\nSection 16 or for any other purpose."}],"balance_after":124779,"source":{"system":"sec-edgar","filing":"0001772259-26-000005","document":"form4-08102026_100800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177225926000005/form4-08102026_100800.xml","form_type":"4"}},{"id":691943,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-10T22:22:07.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":113435,"ownership":{"direct":false,"nature":"By The Li and Cui Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of The Li and Cui Family Trust (the \"Trust\") and have voting and dispositive power over the securities held by the Trust."}],"balance_after":1714117,"source":{"system":"sec-edgar","filing":"0001772259-26-000005","document":"form4-08102026_100800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177225926000005/form4-08102026_100800.xml","form_type":"4"}},{"id":691942,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-10T22:22:07.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":1600682,"ownership":{"direct":false,"nature":"By The Li and Cui Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of The Li and Cui Family Trust (the \"Trust\") and have voting and dispositive power over the securities held by the Trust."}],"balance_after":1600682,"source":{"system":"sec-edgar","filing":"0001772259-26-000005","document":"form4-08102026_100800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177225926000005/form4-08102026_100800.xml","form_type":"4"}},{"id":3114287,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T17:26:35.000Z","date":"2020-06-09","kind":"sale","acquired":false,"shares":300,"price":67.48,"value":20244.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $67.48, and the range of prices were between $67.34 and $67.915.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":540383,"source":{"system":"sec-edgar","filing":"0001209191-20-035621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035621/doc4.xml","form_type":"4"}},{"id":3114286,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T17:26:35.000Z","date":"2020-06-09","kind":"sale","acquired":false,"shares":2585,"price":66.6,"value":172161.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $66.60, and the range of prices were between $66.27 and $67.18.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":540683,"source":{"system":"sec-edgar","filing":"0001209191-20-035621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035621/doc4.xml","form_type":"4"}},{"id":3114285,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T17:26:35.000Z","date":"2020-06-09","kind":"sale","acquired":false,"shares":4515,"price":65.8,"value":297087.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $65.80, and the range of prices were between $65.26 and $66.24.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":543268,"source":{"system":"sec-edgar","filing":"0001209191-20-035621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035621/doc4.xml","form_type":"4"}},{"id":3114284,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T17:26:35.000Z","date":"2020-06-09","kind":"sale","acquired":false,"shares":1688,"price":64.82,"value":109416.16,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $64.82, and the range of prices were between $64.26 and $65.17.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":547783,"source":{"system":"sec-edgar","filing":"0001209191-20-035621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035621/doc4.xml","form_type":"4"}},{"id":3114283,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T17:26:35.000Z","date":"2020-06-09","kind":"sale","acquired":false,"shares":412,"price":63.8,"value":26285.6,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $63.80, and the range of prices were between $63.25 and $64.20.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":549471,"source":{"system":"sec-edgar","filing":"0001209191-20-035621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035621/doc4.xml","form_type":"4"}},{"id":3118129,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":5961,"price":63.92,"value":381027.12,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The weighted average sale price for the transaction reported was $63.92, and the range of prices were between $63.71 and $64.33.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":549883,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118128,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":10667,"price":63.36,"value":675861.12,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The weighted average sale price for the transaction reported was $63.36, and the range of prices were between $62.71 and $63.70.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":555844,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118127,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":1872,"price":62.5,"value":117000.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The weighted average sale price for the transaction reported was $62.50, and the range of prices were between $61.71 and $62.705.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":566511,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118126,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-05","kind":"sale","acquired":false,"shares":1300,"price":65.66,"value":85358.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The weighted average sale price for the transaction reported was $65.66, and the range of prices were between $65.51 and $66.01.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":568383,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118125,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-05","kind":"sale","acquired":false,"shares":4671,"price":65.03,"value":303755.13,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The weighted average sale price for the transaction reported was $65.03, and the range of prices were between $64.46 and $65.41.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":569683,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118124,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-05","kind":"sale","acquired":false,"shares":8927,"price":64.04,"value":571685.08,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The weighted average sale price for the transaction reported was $64.04, and the range of prices were between $63.46 and $64.45.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":574354,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118123,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-05","kind":"sale","acquired":false,"shares":3602,"price":63.04,"value":227070.08,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $63.04, and the range of prices were between $62.445 and $63.42.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":583281,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118122,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":828,"price":69.54,"value":57579.12,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $69.54, and the range of prices were between $69.14 and $69.76.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":586883,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118121,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":2072,"price":68.62,"value":142180.64,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction reported was $68.62, and the range of prices were between $68.11 and $69.11.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":587711,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118120,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":1800,"price":67.52,"value":121536.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $67.52, and the range of prices were between $67.10 and $67.93.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":589783,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118119,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":600,"price":65.81,"value":39486.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $65.81, and the range of prices were between $65.38 and $66.37.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":591583,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118118,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":4012,"price":64.67,"value":259456.04,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $64.67, and the range of prices were between $64.35 and $65.33.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":592183,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118117,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":3688,"price":63.88,"value":235589.44,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $63.88, and the range of prices were between $63.35 and $64.34.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":596195,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118116,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":3600,"price":62.7,"value":225720.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $62.70, and the range of prices were between $62.32 and $63.28.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":599883,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3118115,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:26:43.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":1900,"price":61.76,"value":117344.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $61.76, and the range of prices were between $61.32 and $62.25.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":603483,"source":{"system":"sec-edgar","filing":"0001209191-20-035149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120035149/doc4.xml","form_type":"4"}},{"id":3138626,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":100,"price":60.34,"value":6034.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."}],"balance_after":605383,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3138625,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":6900,"price":59.64,"value":411516.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $59.64, and the range of prices were between $59.13 and $60.07.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":605483,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3138624,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":1400,"price":60.98,"value":85372.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction reported was $60.98, and the range of prices were between $60.60 and $61.25.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":612383,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3138623,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":5100,"price":60.03,"value":306153.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $60.03, and the range of prices were between $59.56 and $60.54.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":613783,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3138622,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":500,"price":59.04,"value":29520.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $59.04, and the range of prices were between $58.545 and $59.46.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":618883,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3138621,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-19","kind":"sale","acquired":false,"shares":400,"price":58.94,"value":23576.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $58.94, and the range of prices were between $58.905 and $58.975.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":619383,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3138620,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-19","kind":"sale","acquired":false,"shares":3000,"price":58.36,"value":175080.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $58.36, and the range of prices were between $57.89 and $58.845.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":619783,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3138619,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-19","kind":"sale","acquired":false,"shares":2400,"price":57.44,"value":137856.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $57.44, and the range of prices were between $56.89 and $57.82.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":622783,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3138618,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:05:26.000Z","date":"2020-05-19","kind":"sale","acquired":false,"shares":1200,"price":56.33,"value":67596.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $56.33, and the range of prices were between $55.785 and $56.750.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":625183,"source":{"system":"sec-edgar","filing":"0001209191-20-031506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120031506/doc4.xml","form_type":"4"}},{"id":3152175,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T20:09:25.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":100,"price":55.16,"value":5516.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $55.16, and the range of prices were between $55.16 and $55.16.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":626383,"source":{"system":"sec-edgar","filing":"0001209191-20-028675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120028675/doc4.xml","form_type":"4"}},{"id":3152174,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T20:09:25.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":4750,"price":54.49,"value":258827.5,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $54.49, and the range of prices were between $54.09 and $55.01.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":626483,"source":{"system":"sec-edgar","filing":"0001209191-20-028675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120028675/doc4.xml","form_type":"4"}},{"id":3152173,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T20:09:25.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":5920,"price":53.49,"value":316660.8,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $53.49, and the range of prices were between $53.09 and $54.07.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":631233,"source":{"system":"sec-edgar","filing":"0001209191-20-028675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120028675/doc4.xml","form_type":"4"}},{"id":3152172,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T20:09:25.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":730,"price":52.53,"value":38346.9,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $52.53, and the range of prices were between $52.05 and $52.975.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":637153,"source":{"system":"sec-edgar","filing":"0001209191-20-028675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120028675/doc4.xml","form_type":"4"}},{"id":3157743,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T18:52:13.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":1330,"price":53.7,"value":71421.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $53.70, and the range of prices were between $53.56 and $54.00.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":637883,"source":{"system":"sec-edgar","filing":"0001209191-20-027784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120027784/doc4.xml","form_type":"4"}},{"id":3157742,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T18:52:13.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":11864,"price":53.05,"value":629385.2,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction reported was $53.05, and the range of prices were between $52.56 and $53.52.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":639213,"source":{"system":"sec-edgar","filing":"0001209191-20-027784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120027784/doc4.xml","form_type":"4"}},{"id":3157741,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T18:52:13.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":5306,"price":52.22,"value":277079.32,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $52.22, and the range of prices were between $51.56 and $52.55.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":651077,"source":{"system":"sec-edgar","filing":"0001209191-20-027784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120027784/doc4.xml","form_type":"4"}},{"id":3157740,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T18:52:13.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":12428,"price":53.13,"value":660299.64,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $53.13, and the range of prices were between $52.91 and $53.51.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":656383,"source":{"system":"sec-edgar","filing":"0001209191-20-027784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120027784/doc4.xml","form_type":"4"}},{"id":3157739,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T18:52:13.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":6072,"price":52.54,"value":319022.88,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $52.54, and the range of prices were between $51.91 and $52.90.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":668811,"source":{"system":"sec-edgar","filing":"0001209191-20-027784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120027784/doc4.xml","form_type":"4"}},{"id":3157738,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T18:52:13.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":5784,"price":54.67,"value":316211.28,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $54.67, and the range of prices were between $54.39 and $54.97.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":674883,"source":{"system":"sec-edgar","filing":"0001209191-20-027784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120027784/doc4.xml","form_type":"4"}},{"id":3157737,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T18:52:13.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":8718,"price":54.04,"value":471120.72,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $54.04, and the range of prices were between $53.39 and $54.38.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":680667,"source":{"system":"sec-edgar","filing":"0001209191-20-027784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120027784/doc4.xml","form_type":"4"}},{"id":3157736,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T18:52:13.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":3998,"price":53.05,"value":212093.9,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $53.05, and the range of prices were between $52.380 and $53.360.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":689385,"source":{"system":"sec-edgar","filing":"0001209191-20-027784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120027784/doc4.xml","form_type":"4"}},{"id":3169952,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-24","kind":"sale","acquired":false,"shares":300,"price":51.98,"value":15594.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $51.98, and the range of prices were between $51.97 and $52.00.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":693383,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3169951,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-24","kind":"sale","acquired":false,"shares":3487,"price":51.31,"value":178917.97,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $51.31, and the range of prices were between $50.93 and $51.90.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":693683,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3169950,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-24","kind":"sale","acquired":false,"shares":3213,"price":50.6,"value":162577.8,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction reported was $50.60, and the range of prices were between $49.92 and $50.91.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":697170,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3169949,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":400,"price":53.82,"value":21528.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $53.82, and the range of prices were between $53.78 and $53.89.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":700383,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3169948,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":1200,"price":53.22,"value":63864.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $53.22, and the range of prices were between $52.75 and $53.70.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":700783,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3169947,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":2200,"price":52.16,"value":114752.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $52.16, and the range of prices were between $51.660 and $52.520.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":701983,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3169946,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":3200,"price":51.02,"value":163264.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $51.02, and the range of prices were between $50.530 and $51.480.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":704183,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3169945,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-22","kind":"sale","acquired":false,"shares":1300,"price":52.41,"value":68133.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $52.41, and the range of prices were between $52.11 and $52.73.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":707383,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3169944,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T20:20:26.000Z","date":"2020-04-22","kind":"sale","acquired":false,"shares":5700,"price":51.64,"value":294348.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $51.64, and the range of prices were between $51.09 and $52.08.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":708683,"source":{"system":"sec-edgar","filing":"0001209191-20-025731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120025731/doc4.xml","form_type":"4"}},{"id":3177657,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:16:20.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":308,"price":51.22,"value":15775.76,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $51.22, and the range of prices were between $51.135 and $51.3275.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":714383,"source":{"system":"sec-edgar","filing":"0001209191-20-024250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120024250/doc4.xml","form_type":"4"}},{"id":3177656,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:16:20.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":200,"price":49.87,"value":9974.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $49.87, and the range of prices were between $49.65 and $50.13.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":714691,"source":{"system":"sec-edgar","filing":"0001209191-20-024250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120024250/doc4.xml","form_type":"4"}},{"id":3177655,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:16:20.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":200,"price":48.44,"value":9688.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $48.44, and the range of prices were between $48.405 and $48.48.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":714891,"source":{"system":"sec-edgar","filing":"0001209191-20-024250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120024250/doc4.xml","form_type":"4"}},{"id":3177654,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:16:20.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":1892,"price":48.75,"value":92235.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $48.75, and the range of prices were between $48.35 and $49.145.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":715091,"source":{"system":"sec-edgar","filing":"0001209191-20-024250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120024250/doc4.xml","form_type":"4"}},{"id":3177653,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:16:20.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":3626,"price":47.82,"value":173395.32,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $47.82, and the range of prices were between $47.32 and $48.29.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":716983,"source":{"system":"sec-edgar","filing":"0001209191-20-024250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120024250/doc4.xml","form_type":"4"}},{"id":3177652,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:16:20.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":5982,"price":46.81,"value":280017.42,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $46.81, and the range of prices were between $46.31 and $47.275.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":720609,"source":{"system":"sec-edgar","filing":"0001209191-20-024250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120024250/doc4.xml","form_type":"4"}},{"id":3179492,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-08","kind":"sale","acquired":false,"shares":100,"price":47.225,"value":4722.5,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."}],"balance_after":726591,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179491,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-08","kind":"sale","acquired":false,"shares":12106,"price":46.43,"value":562081.58,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The weighted average sale price for the transaction reported was $46.43, and the range of prices were between $46.13 and $47.06.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":726691,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179490,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-08","kind":"sale","acquired":false,"shares":6294,"price":45.885,"value":288800.19,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $45.885, and the range of prices were between $45.13 and $46.125.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":738797,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179489,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":5900,"price":45.63,"value":269217.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $45.63, and the range of prices were between $45.32 and $46.235.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":745091,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179488,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":8100,"price":44.96,"value":364176.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction reported was $44.96, and the range of prices were between $44.32 and $45.27.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":750991,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179487,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":4500,"price":43.69,"value":196605.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $43.69, and the range of prices were between $43.21 and $44.16.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":759091,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179486,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":300,"price":45.13,"value":13539.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $45.13, and the range of prices were between $45.09 and $45.15.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":763591,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179485,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":2890,"price":44.22,"value":127795.8,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $44.22, and the range of prices were between $44.09 and $44.505.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":763891,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179484,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":11212,"price":43.72,"value":490188.64,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $43.72, and the range of prices were between $43.085 and $44.08.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":766781,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179483,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":2998,"price":42.61,"value":127744.78,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $42.61, and the range of prices were between $42.08 and $43.04.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":777993,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3179482,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-08T19:21:47.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":1100,"price":41.46,"value":45606.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $41.46, and the range of prices were between $40.96 and $41.94.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":780991,"source":{"system":"sec-edgar","filing":"0001209191-20-023971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120023971/doc4.xml","form_type":"4"}},{"id":3192821,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-27T18:27:15.000Z","date":"2020-03-26","kind":"sale","acquired":false,"shares":200,"price":48.06,"value":9612.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."}],"balance_after":782091,"source":{"system":"sec-edgar","filing":"0001209191-20-021490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021490/doc4.xml","form_type":"4"}},{"id":3192820,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-27T18:27:15.000Z","date":"2020-03-26","kind":"sale","acquired":false,"shares":1648,"price":47.48,"value":78247.04,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $47.48, and the range of prices were between $47.06 and $47.97.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":782291,"source":{"system":"sec-edgar","filing":"0001209191-20-021490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021490/doc4.xml","form_type":"4"}},{"id":3192819,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-27T18:27:15.000Z","date":"2020-03-26","kind":"sale","acquired":false,"shares":3052,"price":46.55,"value":142070.6,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $46.55, and the range of prices were between $46.04 and $47.01.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":783939,"source":{"system":"sec-edgar","filing":"0001209191-20-021490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021490/doc4.xml","form_type":"4"}},{"id":3192818,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-27T18:27:15.000Z","date":"2020-03-26","kind":"sale","acquired":false,"shares":6600,"price":45.37,"value":299442.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $45.37, and the range of prices were between $45.02 and $46.01.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":786991,"source":{"system":"sec-edgar","filing":"0001209191-20-021490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021490/doc4.xml","form_type":"4"}},{"id":3194983,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-25","kind":"sale","acquired":false,"shares":200,"price":47.11,"value":9422.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The weighted average sale price for the transaction reported was $47.11, and the range of prices were between $47.105 and $47.11. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":793591,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194982,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-25","kind":"sale","acquired":false,"shares":2200,"price":46.5,"value":102300.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The weighted average sale price for the transaction reported was $46.50, and the range of prices were between $46.09 and $47.005.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":793791,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194981,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-25","kind":"sale","acquired":false,"shares":13292,"price":45.35,"value":602792.2,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The weighted average sale price for the transaction reported was $45.35, and the range of prices were between $44.97 and $45.91.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":795991,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194980,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-25","kind":"sale","acquired":false,"shares":2100,"price":44.56,"value":93576.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $44.56, and the range of prices were between $43.97 and $44.95.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":809283,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194979,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-24","kind":"sale","acquired":false,"shares":400,"price":43.58,"value":17432.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $43.58, and the range of prices were between $43.345 and $43.88.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":811383,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194978,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-24","kind":"sale","acquired":false,"shares":2100,"price":42.72,"value":89712.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction reported was $42.72, and the range of prices were between $42.30 and $43.19.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":811783,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194977,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-24","kind":"sale","acquired":false,"shares":3200,"price":41.73,"value":133536.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $41.73, and the range of prices were between $41.30 and $42.240.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":813883,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194976,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-24","kind":"sale","acquired":false,"shares":1300,"price":40.75,"value":52975.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $40.75, and the range of prices were between $40.30 and $41.280.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":817083,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194975,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-23","kind":"sale","acquired":false,"shares":1200,"price":39.63,"value":47556.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $39.63, and the range of prices were between $39.38 and $39.94.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":818383,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194974,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-23","kind":"sale","acquired":false,"shares":3000,"price":38.77,"value":116310.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $38.77, and the range of prices were between $38.37 and $39.235.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":819583,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194973,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-23","kind":"sale","acquired":false,"shares":1900,"price":37.88,"value":71972.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $37.88, and the range of prices were between $37.35 and $38.29.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":822583,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3194972,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T18:47:02.000Z","date":"2020-03-23","kind":"sale","acquired":false,"shares":900,"price":36.52,"value":32868.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $36.52, and the range of prices were between $36.225 and $36.70.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":824483,"source":{"system":"sec-edgar","filing":"0001209191-20-021178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120021178/doc4.xml","form_type":"4"}},{"id":3212865,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-12","kind":"sale","acquired":false,"shares":701,"price":37.91,"value":26574.91,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The weighted average sale price for the transaction reported was $37.91, and the range of prices were between $37.480 and $38.385.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":825383,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212864,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-12","kind":"sale","acquired":false,"shares":1878,"price":36.94,"value":69373.32,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The weighted average sale price for the transaction reported was $36.94, and the range of prices were between $36.475 and $37.470.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":826084,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212863,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-12","kind":"sale","acquired":false,"shares":1821,"price":36.07,"value":65683.47,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The weighted average sale price for the transaction reported was $36.07, and the range of prices were between $35.460 and $36.450.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":827962,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212862,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-12","kind":"sale","acquired":false,"shares":2600,"price":34.96,"value":90896.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The weighted average sale price for the transaction reported was $34.96, and the range of prices were between $34.450 and $35.410.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":829783,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212861,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-11","kind":"sale","acquired":false,"shares":1400,"price":43.72,"value":61208.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $43.72, and the range of prices were between $43.390 and $44.30.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":832383,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212860,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-11","kind":"sale","acquired":false,"shares":3200,"price":42.86,"value":137152.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $42.86, and the range of prices were between $42.375 and $43.370.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":833783,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212859,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-11","kind":"sale","acquired":false,"shares":2400,"price":41.5,"value":99600.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction reported was $41.50, and the range of prices were between $41.290 and $42.120.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":836983,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212858,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-11","kind":"sale","acquired":false,"shares":6800,"price":40.61,"value":276148.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $40.61, and the range of prices were between $40.290 and $41.280.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":839383,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212857,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-11","kind":"sale","acquired":false,"shares":4700,"price":40.02,"value":188094.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $40.02, and the range of prices were between $39.280 and $40.270.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":846183,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}},{"id":3212856,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":25040,"kind":"person","name":"Cui Jingrong Jean","position":1,"cik":"0001772259","reported_name":"Cui Jingrong Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:54.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":3400,"price":43.33,"value":147322.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $43.33, and the range of prices were between $43.03 and $44.00.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":850883,"source":{"system":"sec-edgar","filing":"0001209191-20-018656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120018656/doc4.xml","form_type":"4"}}],"next_cursor":"2020-03-12T20:40:54.000000Z,3212856"}